Compare Enveric Biosciences Inc (ENVB) vs Vanguard Global ex-US Real Estate Index Fd ETF (VNQI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? Enveric Biosciences Inc trades at $1.58 (market cap $6.20M), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $45.72. The key difference: Vanguard Global ex-US Real Estate Index Fd ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | VNQI | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | — |
52-Week High | $17.40 | $50.76 |
52-Week Low | $1.27 | $43.26 |
Enterprise Value | $1.30M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.56, up 1.3% on the day, with a bullish technical signal from moving averages and strong analyst support (75% buy ratings). The company reported four consecutive quarterly earnings beats in 2025, including a positive EPS of $0.85 in Q4, while recent news highlights progress in preclinical studies for its non-hallucinogenic psychiatric drug candidate EB-003.
Despite operational losses and negative ROE/ROA, ENVB's consistent earnings surprises and advancing pipeline present speculative growth potential. Key risks include cash burn, clinical trial outcomes, and regulatory hurdles, requiring careful risk assessment by investors.
VNQI (Vanguard Global ex-U.S. Real Estate ETF) trades at $45.82, up 0.57% with a bullish technical signal from moving averages. The ETF provides diversified international real estate exposure across 30+ countries outside the US, featuring a higher dividend yield than domestic alternatives. Recent news highlights comparisons with US-focused REIT ETFs, emphasizing VNQI's global diversification benefits and competitive expense ratio.
The outlook remains positive given international real estate diversification and income appeal, though performance has lagged US counterparts. Key risks include currency fluctuations, geopolitical factors affecting foreign markets, and interest rate sensitivity. Institutional activity shows mixed signals with recent significant position reductions by some funds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Vanguard Global ex-US Real Estate Index Fd ETF
The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →
